TY - JOUR T1 - Identification of known and unknown genes associated with mitral valve prolapse using an exome slice methodology JF - Journal of Medical Genetics JO - J Med Genet SP - 843 LP - 850 DO - 10.1136/jmedgenet-2019-106715 VL - 57 IS - 12 AU - Aniek L van Wijngaarden AU - Yasmine L Hiemstra AU - Tamara T Koopmann AU - Claudia A L Ruivenkamp AU - Emmelien Aten AU - Martin J Schalij AU - Jeroen J Bax AU - Victoria Delgado AU - Daniela Q C M Barge-Schaapveld AU - Nina Ajmone Marsan Y1 - 2020/12/01 UR - http://jmg.bmj.com/content/57/12/843.abstract N2 - Purpose Although a familial distribution has been documented, the genetic aetiology of mitral valve prolapse (MVP) is largely unknown, with only four genes identified so far: FLNA, DCHS1, DZIP1 and PLD1. The aim of this study was to evaluate the genetic yield in known causative genes and to identify possible novel genes associated with MVP using a heart gene panel based on exome sequencing.Methods Patients with MVP were referred for genetic counselling when a positive family history for MVP was reported and/or Barlow’s disease was diagnosed. In total, 101 probands were included to identify potentially pathogenic variants in a set of 522 genes associated with cardiac development and/or diseases.Results 97 (96%) probands were classified as Barlow’s disease and 4 (4%) as fibroelastic deficiency. Only one patient (1%) had a likely pathogenic variant in the known causative genes (DCHS1). However, an interesting finding was that 10 probands (11%) had a variant that was classified as likely pathogenic in six different, mostly cardiomyopathy genes: DSP (1×), HCN4 (1×), MYH6 (1×), TMEM67 (1×), TRPS1 (1×) and TTN (5×).Conclusion Exome slice sequencing analysis performed in MVP probands reveals a low genetic yield in known causative genes but may expand the cardiac phenotype of other genes. This study suggests for the first time that also genes related to cardiomyopathy may be associated with MVP. This highlights the importance to screen these patients and their family for the presence of arrhythmias and of ‘disproportionate’ LV remodelling as compared with the severity of mitral regurgitation, unravelling a possible coexistent cardiomyopathy. ER -